Showing results (561-570 of 591) with videos related to

Sort By:
Pageof 60
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2011
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabJianda Yuan, Matthew Adamow, Brian A Ginsberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamilyJ K Heath, S J White, C N Johnstone, et al.
International Journal of Cancer|March 18, 2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccinationJunji Kawada, Hisashi Wada, Midori Isobe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingDanila Valmori, Naira E Souleimanian, Valeria Tosello, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantQiyuan Chen, Heather Jackson, Phillip Parente, et al.
The Journal of Biological Chemistry|October 11, 1996
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epitheliumB Catimel, G Ritter, S Welt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2013
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG proteinBernardo Sgarbi Reis, Achim A Jungbluth, Denise Frosina, et al.
Pageof 60